Trials / Recruiting
RecruitingNCT01870752
Ovarian Tissue Transplantation
Autologous Orthotopic Transplantation of Previously Cryopreserved Ovarian Tissue
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the efficacy and safety of autologous transplantation of previously cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian insufficiency after cancer treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transplantation of previously cryopreserved ovarian tissu |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2028-06-01
- Completion
- 2028-12-01
- First posted
- 2013-06-06
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01870752. Inclusion in this directory is not an endorsement.